Asia: Guardant Health buys out partners in AMEA JV

Nasdaq-listed Guardant Health, a precision oncology company, has purchased the remaining shares of Guardant Health AMEA held by SoftBank and its affiliates for approximately US$177.8m, giving the company full control over operations throughout the Asia, Middle East and Africa region. In May 2018, Guardant Health and SoftBank Vision Fund established the Guardant Health AMEA joint…

You must be a HMI Subscriber to view this content.

Subscribe Now »